Lyrica (Pregabalin) - New Gabapentinoid with Wide Clinical Application

 

Key Data:

Drug (Brand/Generic)
Lyrica / pregabalin
Company/Licensee
Pfizer
Therapy Class
Antiepileptic
Product Description
GABA analogue
Current Indication
Treatment of neuropathic pain, adjunctive therapy in epilepsy and treatment of generalised anxiety disorder
Market Sector
CNS, pain control
Development Status
Approved for neuropathic pain in Europe and the US and additionally for partial seizures in Europe and the US



Home
New On This Site
Products & Services
Company A-Z
Industry Projects
Features
White Papers
Jobs & Careers
Industry News
Gallery
Events & Exhibitions
Newsletter
Advertise With Us
About Us
Client Area


RSS What is RSS
For every phase of your drug development